A series of 5-substituted 2-amino-4,6-dihydroxypyrimidines were prepared by a modified condensation of the corresponding monosubstituted malonic acid diesters with guanidine in an excess of sodium ethoxide. The optimized procedure using Vilsmeier-Haack-Arnold reagent, followed by immediate deprotection of the (dimethylamino)methylene protecting groups, has been developed to convert the 2-amino-4,6-dihydroxypyrimidine analogs to novel 5-substituted 2-amino-4,6-dichloropyrimidines in high yields. Pilot screening for biological properties of the prepared compounds was done in mouse peritoneal cells using the in vitro nitric oxide (NO) assay. Irrespective of the substituent at the 5 position, 2-amino-4,6-dichloropyrimidines inhibited immune-activated NO production. The most effective was 5-fluoro-2-amino-4,6-dichloropyrimidine with an IC 50 of 2 µM (higher activity than the most potent reference compound) while the IC 50s of other derivatives were within the range of 9-36 µM. The 2-amino-4,6-dihydroxypyrimidine counterparts were devoid of any NO-inhibitory activity. The compounds had no suppressive effects on the viability of cells. The Mechanism of action remains to be elucidated.

Institute of Experimental Medicine Academy of Sciences of the Czech Republic Vídeňská 1083 142 20 Prague 4 Czech Republic

Institute of Organic Chemistry and Biochemistry Academy of Sciences of the Czech Republic v v i Flemingovo nám 2 166 10 Prague 6 Czech Republic

Institute of Pharmacology and Toxicology Faculty of Medicine in Pilsen Charles University Karlovarská 48 30 166 Pilsen Czech Republic

Zobrazit více v PubMed

Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu HQ, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD. Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H-4 receptor ligands. J Med Chem. 2008;51:6571–6580. doi: 10.1021/jm8005959. PubMed DOI

Arvanitis AG, Gilligan PJ, Chorvat RJ, Cheeseman RS, Christos TE, Bakthavatchalam R, Beck JP, Cocuzza AJ, Hobbs FW, Wilde RG, Arnold C, Chidester D, Curry M, He L, Hollis A, Klaczkiewicz J, Krenitsky PJ, Rescinito JP, Scholfield E, Culp S, De Souza EB, Fitzgerald L, Grigoriadis D, Tam SW, Shen HL. Non-peptide corticotropin-releasing hormone antagonists: syntheses and structure-activity relationships of 2-anilinopyrimidines and -triazines. J Med Chem. 1999;42:805–818. doi: 10.1021/jm980222w. PubMed DOI

Baraldi PG, Bovero A, Fruttarolo F, Romagnoli R, Tabrizi MA, Preti D, Varani K, Borea PA, Moorman AR. New strategies for the synthesis of A(3) adenosine receptor antagonists. Bioorg Med Chem. 2003;11:4161–4169. doi: 10.1016/S0968-0896(03)00484-X. PubMed DOI

Beattie JF, Breault GA, Ellston RP, Green S, Jewsbury PJ, Midgley CJ, Naven RT, Minshull CA, Pauptit RA, Tucker JA, Pease JE. Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 1: identification and optimisation of substituted 4,6-bis anilino pyrimidines. Bioorg Med Chem Lett. 2003;13:2955–2960. doi: 10.1016/S0960-894X(03)00202-6. PubMed DOI

Bogdan C, Werner E, Stenger S, Wachter H, Röllinghoff M, Werner-Felmayer G. 2,4-Diamino-6-hydroxypyrimidine, an inhibitor of tetrahydrobiopterin synthesis, downregulates the expression of iNOS protein and mRNA in primary murine macrophages. FEBS Lett. 1995;363:69–74. doi: 10.1016/0014-5793(95)00284-G. PubMed DOI

Breault GA, Ellston RP, Green S, James SR, Jewsbury PJ, Midgley CJ, Pauptit RA, Minshull CA, Tucker JA, Pease JE. Cyclin-dependent kinase 4 inhibitors as a treatment for cancer. Part 2: identification and optimisation of substituted 2,4-bis anilino pyrimidines. Bioorg Med Chem Lett. 2003;13:2961–2966. doi: 10.1016/S0960-894X(03)00203-8. PubMed DOI

Daluge SM, Martin MT, Sickles BR, Livingston DA. An efficient, scalable synthesis of the HIV reverse transcriptase inhibitor Ziagen (1592U89) Nucleos Nucleot Nuc Acids. 2000;19:297–327. doi: 10.1080/15257770008033011. PubMed DOI

De Clercq E, Holý A. Acyclic nucleoside phosphonates: a key class of antiviral drugs. Nature Rev Drug Disc. 2005;4:928–940. doi: 10.1038/nrd1877. PubMed DOI

Flore O, Marcialis MA, Marongiu ME, Pompei R, La Colla P, Loddo B. Dichloropyrimidines: specific inhibitors of virus growth. Experientia. 1977;33:1155–1157. doi: 10.1007/BF01922299. PubMed DOI

Harmatha J, Buděšínský M, Vokáč K, Kostecká P, Kmoníčková E, Zídek Z. Trilobolide and related sesquiterpene lactones from Laser trilobum possessing immunobiological properties. Fitoterapia. 2013;89:157–166. doi: 10.1016/j.fitote.2013.05.025. PubMed DOI

Hitchings GH. Selective inhibitors of dihydrofolate reductase (Nobel Lecture) Angew Chem Int Edit Eng. 1989;28:879–888. doi: 10.1002/anie.198908791. PubMed DOI

Hocková D, Holý A, Masojidková M, Andrei G, Snoeck R, De Clercq E, Balzarini J. 5-Substituted-2,4-diamino-6-2-(phosphonomethoxy)ethoxylpyrimidines acyclic nucleoside phosphonate analogues with antiviral activity. J Med Chem. 2003;46:5064–5073. doi: 10.1021/jm030932o. PubMed DOI

Hocková D, Holý A, Masojidková M, Andrei G, Snoeck R, De Clercq E, Balzarini J. Synthesis and antiviral activity of 2,4-diamino-5-cyano-6-2-(phosphonomethoxy)ethoxy pyrimidine and related compounds. Bioorg Med Chem. 2004;12:3197–3202. doi: 10.1016/j.bmc.2004.04.002. PubMed DOI

Holý A. Phosphonomethoxyalkyl analogs of nucleotides. Curr Pharm Des. 2003;9:2567–2592. doi: 10.2174/1381612033453668. PubMed DOI

Ikemoto K, Matsumoto T, Ohtsuki M, Itoh M, Tada S, Udagawa Y, Sumi-Ichinose C, Kondo K, Nomura T. 2,4-Diamino-6-hydroxypyrimidine (DAHP) suppresses cytokine-induced VCAM-1 expression on the cell surface of human umbilical vein endothelial cells in a BH(4)-independent manner. Biochim Biophys Acta. 2008;1780:960–965. doi: 10.1016/j.bbagen.2008.03.012. PubMed DOI

Jang MY, Lin YA, De Jonghe S, Gao LJ, Vanderhoydonck B, Froeyen M, Rozenski J, Herman J, Louat T, Van Belle K, Waer M, Herdewijn P. Discovery of 7-N-piperazinylthiazolo 5,4-d pyrimidine analogues as a novel class of immunosuppressive agents with in vivo biological activity. J Med Chem. 2011;54:655–668. doi: 10.1021/jm101254z. PubMed DOI

Jansa P, Hradil O, Baszczyňski O, Dračínský M, Klepetářová B, Holý A, Balzarini J, Janeba Z. An efficient microwave-assisted synthesis and biological properties of polysubstituted pyrimidinyl- and 1,3,5-triazinylphosphonic acids. Tetrahedron. 2012;68:865–871. doi: 10.1016/j.tet.2011.11.040. PubMed DOI PMC

Kmoníčková E, Melkusová P, Farghali H, Holý A, Zídek Z. Nitric oxide production in mouse and rat macrophages: a rapid and efficient assay for screening of drugs immunostimulatory effects in human cells. Nitric Oxide. 2007;17:160–169. doi: 10.1016/j.niox.2007.06.006. PubMed DOI

Kolinsky MA, Gross SS. The mechanism of potent GTP cyclohydrolase I inhibition by 2,4-diamino-6-hydroxypyrimidine: requirement of the GTP cyclohydrolase I feedback regulatory protein. J Biol Chem. 2004;279:40677–40682. doi: 10.1074/jbc.M405370200. PubMed DOI

La Colla P, Marcialis MA, Flore O, Schivo ML, Garzia A, Loddo B. Irreversible inactivation by 2-amino-4,6-dichloropyrimidine of certain structural proteins of poliovirus. Experientia. 1975;31:797–798. doi: 10.1007/BF01938471. PubMed DOI

La Colla P, Marcialis MA, Flore O, Sau M, Garzia A, Loddo B. Specific inhibition of virus multiplication by bichlorinated pyrimidines. Ann N Y Acad Sci USA. 1977;284:294–304. doi: 10.1111/j.1749-6632.1977.tb21964.x. PubMed DOI

Lagoja IM. Pyrimidine as constituent of natural biologically active compounds. Chem Biodivers. 2005;2:1–50. doi: 10.1002/cbdv.200490173. PubMed DOI

Marcialis MA, Schivo ML, Atzeni A, Garzia A, Loddo B. On the mechanism of the inhibitory action of 2-amino-4,6-dichloropyrimidine on poliovirus growth. Experientia. 1973;29:1559–1561. doi: 10.1007/BF01943917. PubMed DOI

Marcialis MA, Flore O, Firinu A, La Colla P, Garzia A, Loddo B. In vitro and in vivo inhibitory action of 2-amino-4,6-dichloropyrimidine on polio and herpes virus. Experientia. 1974;30:1272–1273. doi: 10.1007/BF01945180. PubMed DOI

Marcialis MA, Flore O, Marongiu ME, Pompei R, Pani A, Manconi PE. On the inhibitory effect of 2-amino-4,6-dichloropyrimidine on growth of vaccinia virus. Experientia. 1979;35:321–322. doi: 10.1007/BF01964326. PubMed DOI

Marletta MA, Yoon PS, Iyengar R, Leaf CD, Wishnok JS. Macrophage oxidation of l-arginine to nitrite and nitrate: nitric oxide is an intermediate. Biochemistry. 1988;27:8706–8711. doi: 10.1021/bi00424a003. PubMed DOI

Naesens L, Lenaerts L, Andrei G, Snoeck R, Van Beers D, Holý A, Balzarini J, De Clercq E. Antiadenovirus activities of several classes of nucleoside and nucleotide analogues. Antimicrob Agents Chem. 2005;49:1010–1016. doi: 10.1128/AAC.49.3.1010-1016.2005. PubMed DOI PMC

Nencka R, Votruba I, Hřebabecký H, Jansa P, Tloust’ová E, Horská K, Masojídková M, Holý A. Discovery of 5-substituted-6-chlorouracils as efficient inhibitors of human thymidine phosphorylase. J Med Chem. 2007;50:6016–6023. doi: 10.1021/jm070644i. PubMed DOI

Patel PR, Ramalingan C, Park YT. Synthesis and antimicrobial evaluation of guanylsulfonamides. Bioorg Med Chem Lett. 2007;17:6610–6614. doi: 10.1016/j.bmcl.2007.09.060. PubMed DOI

Procházková E, Jansa P, Březinová A, Čechová L, Mertlíková-Kaiserová H, Holý A, Dračínský M. Compound instability in dimethyl sulphoxide, case studies with 5-aminopyrimidines and the implications for compound storage and screening. Bioorg Med Chem Lett. 2012;22:6405–6409. doi: 10.1016/j.bmcl.2012.08.065. PubMed DOI

Procházková E, Jansa P, Dračínský M, Holý A, Mertliková-Kaiserová H. Determination of the antioxidative activity of substituted 5-aminopyrimidines. Free Radical Res. 2012;46:61–67. doi: 10.3109/10715762.2011.638292. PubMed DOI

Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev. 1998;50:413–492. PubMed

Reichardt C. Vilsmeier–Haack–Arnold formylations of aliphatic substrates with N-chloromethylene-N, N-dimethylammonium salts. J Prakt Chem. 1999;341:609–615. doi: 10.1002/(SICI)1521-3897(199910)341:7<609::AID-PRAC609>3.0.CO;2-0. DOI

Rembold H, Schramm HJ. Kondensation des 2.4-diamino-6-hydroxy-pyrimidins mit Aldosen. Chem Ber. 1963;96:2786–2797. doi: 10.1002/cber.19630961038. DOI

Rostom SAF, Ashour HMA, El Razik HAA. Synthesis and biological evaluation of some novel polysubstituted pyrimidine derivatives as potential antimicrobial and anticancer agents. Arch Pharm. 2009;342:299–310. doi: 10.1002/ardp.200800223. PubMed DOI

Schostarez HJ (1992) A process for the preparation of 5-fluoro-6-(1-piperidinyl)-2,4-pyrimidinediamine 3-oxide (5-fluorominoxidil) and is use as hair growth agent and antihypertensive. WO9208705A1, p 19

Stenger S, Thuring H, Rollinghoff M, Manning P, Bogdan C. L-N6-(1-iminoethyl)-lysine potently inhibits inducible nitric oxide synthase and is superior to NG-monomethyl-arginine in vitro and in vivo. Eur J Pharmacol. 1995;294:703–712. doi: 10.1016/0014-2999(95)00618-4. PubMed DOI

Sung YJ, Hotchkiss JH, Dietert RR. 2,4-Diamino-6-hydroxypyrimidine, an inhibitor of GTP cyclohydrolase I, suppresses nitric oxide production by chicken macrophages. Int J Immunopharmacol. 1994;16:101–108. doi: 10.1016/0192-0561(94)90065-5. PubMed DOI

Suzuki N, Shiota T, Watanabe F, Haga N, Murashi T, Ohara T, Matsuo K, Omori N, Yari H, Dohi K, Inoue M, Iguchi M, Sentou J, Wada T. Discovery of novel 5-alkynyl-4-anilinopyrimidines as potent, orally active dual inhibitors of EGFR and Her-2 tyrosine kinases. Bioorg Med Chem Lett. 2012;22:456–460. doi: 10.1016/j.bmcl.2011.10.103. PubMed DOI

Tegeder I, Costigan M, Griffin RS, Abele A, Belfer I, Schmidt H, Ehnert C, Nejim J, Marian C, Scholz J, Wu T, Allchorne A, Diatchenko L, Binshtok AM, Goldman D, Adolph J, Sama S, Atlas SJ, Carlezon WA, Parsegian A, Lötsch J, Fillingim RB, Maixner W, Geisslinger G, Max MB, Woolf CJ. GTP cyclohydrolase and tetrahydrobiopterin regulate pain sensitivity and persistence. Nat Med. 2006;12:1269–1277. doi: 10.1038/nm1490. PubMed DOI

Undheim K, Benneche T (1996) 6.02—Pyrimidines and their benzo derivatives. In: Katritzky AR, Rees CW, Scriven EFV (eds) Comprehensive heterocyclic chemistry II; 602—pyrimidines and their benzo derivatives. Pergamon, Oxford, pp 93–231

Xu Y, Krukoff TL. Adrenomedullin stimulates nitric oxide release from SK-N-SH human neuroblastoma cells by modulating intracellular calcium mobilization. Endocrinology. 2005;146:2295–2305. doi: 10.1210/en.2004-1354. PubMed DOI

Ying C, Holý A, Hocková D, Havlas Z, De Clercq E, Neyts J. Novel acyclic nucleoside phosphonate analogues with potent anti-hepatitis B virus activities. Antimicrob Agents Chem. 2005;49:1177–1180. doi: 10.1128/AAC.49.3.1177-1180.2005. PubMed DOI PMC